Bahrain vs Bhutan: HIV-positive TB patients on ART (antiretroviral therapy)
Bahrain
100.0%
in 2023
Bhutan
100.0%
in 2024
Bahrain rank
1st
Bhutan rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bahrain
- Bhutan
How they compare
Bahrain currently reports 100.0% against 100.0% in Bhutan, a difference of 0.0%.
Across all 10 years both countries report, Bhutan has been ahead every year.
Bahrain ranks 1st and Bhutan ranks 1st of 144 countries.
Bhutan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | Bhutan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 100.0% | 87.0% | Bhutan |
| 2010s | 63.5% | 87.5% | 24.0% | Bhutan |
| 2020s | 57.5% | 100.0% | 42.5% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bahrain or Bhutan?
- Bahrain, at 100.0% against 100.0% in Bhutan as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bahrain and Bhutan?
- 0.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Bhutan?
- 10 years are reported by both, from 2008 to 2023.
- How do Bahrain and Bhutan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bahrain ranks 1st and Bhutan ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.